Is a
Clinical Study attributes
NCT Number
Health Conditions in Trial
Trial Recruitment Size
120
Trial Sponsor
Clinical Trial Start Date
2008
0Primary Completion Date
2008
0Study Completion Date
2008
0Clinical Trial Study Type
Interventional0
Interventional Trial Purpose
Treatment0
Intervention Type
Drug0
Intervention Name
ST-246 Days 1 - 30
ST-246 Days 11 - 130
Interventional Trial Phase
Phase 10
Official Name
A Phase I Randomized, Double-Blind, Crossover, Exploratory Study of the Pharmacokinetics of a Single Oral Dose of Form I Versus Form V Capsules of the Anti-Orthopoxvirus Compound ST-246® in Fed Normal Healthy Volunteers0
Last Updated
June 29, 2015
0Allocation Type
Randomized0
Intervention Model
Crossover Assignment0
Masking Type
Triple0
Masked Party
Care Provider0
Participant0
Investigator0
Study summary
The purpose of this study was to evaluate the pharmacokinetic parameters and safety of a single dose of ST-246 400mg Form I versus ST-246 400mg Form V capsules in fed normal healthy volunteers.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
